In The News

Asia-based Attorneys Discuss China’s New Anti-Commercial Bribery Campaign in Law360

Practices: Litigation, Business & Commercial Litigation, Government Enforcement / White Collar Criminal Defense, Health Care

Government enforcement counsel Katherine Wang and associate David Zhang authored an article for Law360 that examines the potential impact of China’s new three-year anti-commercial bribery campaign intended to specifically target 10 large cities and provinces.

The Feb. 27 article, titled “China Anti-Bribery Rules Raise Questions For Life Sciences” highlights China’s decision to implement a blacklist of individuals and companies in the health care industry that have been subject to bribery-related investigations, penalties or convictions. The article also discusses Nine Prohibitions to Strengthen Ethical Conduct in the Healthcare Industry, as determined by China’s National Health and Family Planning Commission. 

Cookie Settings